- The secondaries market has opened up again, particularly in the GP-led space. Unigestion’s latest secondary programme is on track to close seven secondary deals in 2020.
- The recovery in LP stake sales has lagged on valuation concerns while demand for higher quality deals has supported high pricing relative to NAV.
- GPs are looking for alternative liquidity solutions in light of delayed exits and lower DPIs. Therefore, GP-led transaction volumes are likely to increase into 2021.
Since the onset of the Covid-19 crisis, the secondaries market has recovered in the GP-led space faster than in the LP stakes space, according to David Swanson, Principle, Unigestion Private Equity. “If you had asked me in July how the year would progress, I would have said it would be a down year with the pandemic and lack of deal volume, but now 2020 might even be a record year of deployment for us, since the market has opened up again, particularly in the GP-led space.”
What is driving the recovery of the secondaries market, what opportunities exist in GP-led transactions and how has Unigestion been able to close deals in this challenging environment?
LP stake sales vs GP-led transactions
LP stake sales have taken longer to recover following June valuations and the recovery of the public market, since sellers are exercising caution. “As a seller, it has made sense to wait on the sidelines for private market valuations to follow,” says Swanson. “Secondary funds that focus solely on LP stakes have had a deployment pause, but volumes will come back up; LP stakes made up around 60-70% of the market in 2019 and we are likely to return to those levels if there is no significant worsening of the pandemic.”
Swanson says there has continued to be less distress than was initially anticipated. Nevertheless, that distress could still materialise, given the uncertain direction of the pandemic: “No seller wants to be distressed and sell assets at a big discount, and they will exhaust all other alternatives first. But we still could see distress – the pandemic is getting worse in some areas and there is a lot of uncertainty as to its continued impact.”
Pricing has remained punchy following Q1 and Q2 disparities. “There has been a flight to quality, particularly where company business models and their resilience can truly be understood,” says Swanson, reflecting the bifurcation seen in the current buyout market. “For quality positions there is not much of a discount to net asset values. However, holding periods have been pushed out, and that has led investors to underwrite greater time until exit.”
A growing opportunity in GP-led deals
The trend towards longer holding periods in a challenging exit environment is likely to affect the market significantly going forward, presenting new opportunities for secondaries and differentiated liquidity solutions. “We are in an environment where there has not been significant DPI generation for GPs,” says Swanson. “Portfolio companies that were meant to hit certain performance targets in 2020 are now expected to hit those targets in 2021 or beyond. This has delayed exits and therefore brought GPs to the secondary market for a solution. A GP-led deal can solve the tension between the desire to generate liquidity and the GP’s desire to not sell assets at a sub-optimal time.”
For quality positions there is not much of a discount to net asset values. However, holding periods have been pushed out, and that has led investors to underwrite greater time until exit.
Swanson predicts a high volume of GP-led secondaries deals in Q4 2020 and in 2021, accompanied by a rebound of the LP stakes market. “LPs will, at some point, need to rebalance, trim old positions, etc. Once there is more clarity around net asset values in Q3 and Q4, you could see sellers of LP interests return to market and transact off those reference dates. However, the pandemic, the uncertainty following the US election, Brexit and other geopolitical events could lead to a lot of volatility, which will affect how buyers and sellers approach the market.”
The pandemic, the uncertainty following the US election, Brexit and other geopolitical events could lead to volatility, which will affect how buyers and sellers approach the market.
Closing deals in a crisis
Of Unigestion’s own strategy, Swanson says: “Deployment is going well so far for our latest programme; we will have done seven deals by the end of the year, having made the first one in September.” Unigestion is on the road for its fifth secondaries strategy, which has a target of EUR 700m. The strategy focuses on small-cap, non-auctioned, GP-led deals valued at less than EUR 50m, although it could opportunistically target LP stakes.
Deployment is going well so far; we will have done seven deals by the end of the year, having made the first one in September.
The development of digital due diligence and the adaptation to home working has been key in keeping up deployment, Swanson says. “In all our deals, we want to meet management teams of the underlying companies, and continue to do deep due diligence, and we have still been able to do that. I think the global response to accommodate working from home has been very impressive. The technology and the resources that have come into play have really enabled a thorough diligence process.”
Past performance is no guide to the future, the value of investments, and the income from them change frequently, may fall as well as rise, there is no guarantee that your initial investment will be returned. This document has been prepared for your information only and must not be distributed, published, reproduced or disclosed by recipients to any other person. It is neither directed to, nor intended for distribution or use by, any person or entity who is a citizen or resident of, or domiciled or located in, any locality, state, country or jurisdiction where such distribution, publication, availability or use would be contrary to law or regulation.
This is a promotional statement of our investment philosophy and services only in relation to the subject matter of this presentation. It constitutes neither investment advice nor recommendation. This document represents no offer, solicitation or suggestion of suitability to subscribe in the investment vehicles to which it refers. Any such offer to sell or solicitation of an offer to purchase shall be made only by formal offering documents, which include, among others, a confidential offering memorandum, limited partnership agreement (if applicable), investment management agreement (if applicable), operating agreement (if applicable), and related subscription documents (if applicable). Please contact your professional adviser/consultant before making an investment decision.
Where possible we aim to disclose the material risks pertinent to this document, and as such these should be noted on the individual document pages. The views expressed in this document do not purport to be a complete description of the securities, markets and developments referred to in it. Reference to specific securities should not be considered a recommendation to buy or sell. Unigestion maintains the right to delete or modify information without prior notice. Unigestion has the ability in its sole discretion to change the strategies described herein.
Investors shall conduct their own analysis of the risks (including any legal, regulatory, tax or other consequences) associated with an investment and should seek independent professional advice. Some of the investment strategies described or alluded to herein may be construed as high risk and not readily realisable investments, which may experience substantial and sudden losses including total loss of investment. These are not suitable for all types of investors.
To the extent that this report contains statements about the future, such statements are forward-looking and subject to a number of risks and uncertainties, including, but not limited to, the impact of competitive products, market acceptance risks and other risks. Actual results could differ materially from those in the forward-looking statements. As such, forward looking statements should not be relied upon for future returns. Targeted returns reflect subjective determinations by Unigestion based on a variety of factors, including, among others, internal modeling, investment strategy, prior performance of similar products (if any), volatility measures, risk tolerance and market conditions. Targeted returns are not intended to be actual performance and should not be relied upon as an indication of actual or future performance.
No separate verification has been made as to the accuracy or completeness of the information herein. Data and graphical information herein are for information only and may have been derived from third party sources. Unigestion takes reasonable steps to verify, but does not guarantee, the accuracy and completeness of information from third party sources. As a result, no representation or warranty, expressed or implied, is or will be made by Unigestion in this respect and no responsibility or liability is or will be accepted. All information provided here is subject to change without notice. It should only be considered current as of the date of publication without regard to the date on which you may access the information. Rates of exchange may cause the value of investments to go up or down. An investment with Unigestion, like all investments, contains risks, including total loss for the investor.
Unigestion Secondary V (USec V) has been created as a SCS-SICAV-RAIF in Luxembourg and will qualify as an Alternative Investment Fund (AIF) within the meaning of the law dated 12 July 2013 on Alternative Investment Fund Managers implementing the Directive 2011/61/EU (AIFMD). As a result, units of this vehicle may be offered only to professional investors and may not be distributed on a public basis in or from any country where such distribution would be prohibited by law. This document contains a preliminary summary of the purpose and principal business terms of an investment in Unigestion Secondary V. This summary does not purport to be complete and is qualified in its entirety by reference to the more detailed discussion to take place with the AIF. Unigestion Secondary V will have the ability in its sole discretion to change the strategies described herein. Before making a decision to invest in Unigestion Secondary V, you are advised to consult with your tax, legal and financial advisors.
Additional Information for US Investors
The performance figures are based on estimated fees and expenses as well as on the underlying strategy’s estimated performances given by fund managers, administrators, custodians and third party sources at a given date. Where performance is reflected gross of fees, potential investors should be aware that the inclusion of fees, costs and charges will reduce the overall value of performance. Unless otherwise stated, the performance data source are Unigestion, Bloomberg and Compustat.
This information is provided to you solely to give you background information relating to Unigestion, certain strategies it implements and currently offers. Before making an investment decision with respect to the strategy discussed herein, potential investors are advised to consult with their tax, legal, ERISA and financial advisors. Note that not all strategies may be available or suitable for investment by U.S. investors.
This document may contain forward-looking statements, including observations about markets and industry and regulatory trends as of the original date of this document. Forward-looking statements may be identified by, among other things, the use of words such as “expects,” “anticipates,” “believes,” or “estimates,” or the negatives of these terms, and similar expressions. Forward-looking statements reflect Unigestion’s views as of such date with respect to possible future events. Actual results could differ materially from those in the forward-looking statements as a result of factors beyond a strategy’s or Unigestion’s control. Readers are cautioned not to place undue reliance on such statements. No party has an obligation to update any of the forward-looking statements in this document
Return targets or objectives, if any, are used for measurement or comparison purposes and only as a guideline for prospective investors to evaluate a particular investment program’s investment strategies and accompanying information. Performance may fluctuate, especially over short periods. Targeted returns should be evaluated over the time period indicated and not over shorter periods.
The past performance of Unigestion, its principals, shareholders, or employees is not indicative of future returns.
Except where otherwise specifically noted, the information contained herein, including performance data and assets under management, relates to the entire affiliated group of Unigestion entities over time including that of Unigestion UK. Such information is intended to provide the reader with background regarding the services, investment strategies and personnel of the Unigestion entities. No guarantee is made that all or any of the individuals involved in generating the performance on behalf the other Unigestion entities will be involved in managing any client account on behalf of Unigestion U.K. More specific information regarding Unigestion UK is set forth herein where indicated and is available on request.
There is no guarantee that Unigestion will be successful in achieving any investment objectives. An investment strategy contains risks, including the risk of complete loss.
The risk management practices and methods described herein are for illustrative purposes only and are subject to modification.
Legal Entities Disseminating This Document
This material is disseminated in the United Kingdom by Unigestion (UK) Ltd., which is authorized and regulated by the Financial Conduct Authority (“FCA”).
This information is intended only for professional clients and eligible counterparties, as defined in MiFID directive and has therefore not been adapted to retail clients.
This material is disseminated in the U.S. by Unigestion (UK) Ltd., which is registered as an investment adviser with the U.S. Securities and Exchange Commission (“SEC”). This information is intended only for institutional clients and qualified purchasers as defined by the SEC and has therefore not been adapted to retail clients.
This material is disseminated in the European Union by Unigestion Asset Management (France) SA which is authorized and regulated by the French “Autorité des Marchés Financiers” (“AMF”).
This information is intended only for professional clients and eligible counterparties, as defined in the MiFID directive and has therefore not been adapted to retail clients.
This material is disseminated in Canada by Unigestion Asset Management (Canada) Inc. which is registered as a portfolio manager and/or exempt market dealer in nine provinces across Canada and also as an investment fund manager in Ontario, Quebec and Newfoundland & Labrador. Its principal regulator is the Ontario Securities Commission (“OSC”).
This material may also be distributed by Unigestion SA which has an international advisor exemption in Quebec, Saskatchewan and Ontario. Unigestion SA’s assets are situated outside of Canada and, as such, there may be difficulty enforcing legal rights against it.
This material is disseminated in Switzerland by Unigestion SA which is authorized and regulated by the Swiss Financial Market Supervisory Authority (“FINMA”).
Document issued November 2020.